
“The quality and coverage of B2B contact database are very impressive...”
Mark J.
`
+5
Founded in 2014, HaploX aims to integrate liquid biopsy technology, gene sequencing, artificial intelligence, big data, and other technologies to improve the management of cancer patients. HaploXs technologies include tools for capturing circulating tumor DNA; extracting and amplifying ultra-low concentrations of DNA from liquid samples; performing tagged sequencing; and managing and analyzing the resulting data. Presently, HaploXs polycentric global distribution include: Shenzhen R & D Headquarter, Third-party Medical Laboratory, GMP Factory, US R & D center and ShangRao International Precision Medical Health Industrial Park. HaploX obtained a certificate of participation from EMQN(The European Molecular Genetics Quality Network) in 2017 and...
Liquid biopsy,gene sequencing,artificial intelligence,precise medical,big genomic data,ultramicro-tumor gene detection,tumor prevention,tumor diagnosis,tumor prognosis and monitoring,and personalized cancer therapy
Haplox biotechnology operates in the Biotechnology research industry.
Haplox biotechnology's revenue is 11m - 100m
Haplox biotechnology has 11 - 50 employees.
Get Started with the Free Forever plan! No credit card needed. Enjoy up to 10,000 free email credits per month at no cost.
Start Prospecting from Clodura.AI's database of 600M+ verified B2B contacts and 120M+ direct dials along with 18M+ companies' org charts.
Unlock the prospect's contact details, including verified email, direct dials, add them to cadence, and close more deals.